Theleme Partners LLP

Q3 2021 13F Holdings Report, Restatement, Stock Holdings

Signature - Title
Lucy Elwes - Chief Compliance Officer
Location
London, United Kingdom
Holdings as of
30 Sep 2021
Value $
$3.5B
Num holdings
7
Date filed
26 May 2022, 12:04
Form type
13F-HR/A-1 - Restatement
Description
All US holdings of this investor are reported in this report. Top holdings included MRNA, WFC, META, AA, and TMUS.
Previous filing
Q2 2021 - 13 Aug 2021
Next filing
Q4 2021 - 26 May 2022
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2021 Q3 - Restatement compared to 2021 Q2 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Lucy Elwes Chief Compliance Officer London, United Kingdom 26 May 2022

This is an amendment to reflect corrections to Column 7 and Column 8 of the Information Table.

Other Included Managers (1):

Num Name Location File Number
1 Theleme Master Fund Ltd Dublin 028-14311